REPORT ID 17949

Global Opioid Induced Constipation Drugs Market Size, Status and Forecast 2022

Publish Date
03-Oct-17
Pages
100
Format
Electronic (PDF)

This report studies the global Opioid Induced Constipation Drugs market, analyzes and researches the Opioid Induced Constipation Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Ironwood Pharmaceuticals Inc
    Daiichi Sankyo Co Ltd
    Pfizer
    Progenics Pharmaceuticals Inc
    Shionogi & Co., Ltd
    Allergan Plc
    Nektar Therapeutics
    Purdue Pharma
    S.L.A. Pharma AG
    Mundipharma International Limited
    Ono Pharmaceutical Co., Ltd
    Takeda Pharmaceutical Company Limited
    Theravance Biopharma Inc
    Valeant Pharmaceuticals International
    Cosmo Pharmaceuticals SA
    Daewoong Pharmaceutical
    C.B. Fleet Company
    Sucampo Pharmaceuticals

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Opioid Induced Constipation Drugs can be split into
    Lubiprostone
    Methyl Naltrexone Bromide
    Naldemedine
    Alvimopan
    Other

Market segment by Application, Opioid Induced Constipation Drugs can be split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Opioid Induced Constipation Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Opioid Induced Constipation Drugs
    1.1  Opioid Induced Constipation Drugs Market Overview
        1.1.1 Opioid Induced Constipation Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Opioid Induced Constipation Drugs Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Opioid Induced Constipation Drugs Market by Type
        1.3.1 Lubiprostone
        1.3.2 Methyl Naltrexone Bromide
        1.3.3 Naldemedine
        1.3.4 Alvimopan
        1.3.5 Other
    1.4 Opioid Induced Constipation Drugs Market by End Users/Application
        1.4.1 Hospital Pharmacies
        1.4.2 Retail Pharmacies
        1.4.3 Online Pharmacies

2 Global Opioid Induced Constipation Drugs Competition Analysis by Players
    2.1 Opioid Induced Constipation Drugs Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Ironwood Pharmaceuticals Inc
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Daiichi Sankyo Co Ltd
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Pfizer
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Progenics Pharmaceuticals Inc
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Shionogi & Co., Ltd
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Allergan Plc
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Nektar Therapeutics
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Purdue Pharma
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 S.L.A. Pharma AG
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Mundipharma International Limited
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Ono Pharmaceutical Co., Ltd
    3.12 Takeda Pharmaceutical Company Limited
    3.13 Theravance Biopharma Inc
    3.14 Valeant Pharmaceuticals International
    3.15 Cosmo Pharmaceuticals SA
    3.16 Daewoong Pharmaceutical
    3.17 C.B. Fleet Company
    3.18 Sucampo Pharmaceuticals

4 Global Opioid Induced Constipation Drugs Market Size by Type and Application (2012-2017)
    4.1 Global Opioid Induced Constipation Drugs Market Size by Type (2012-2017)
    4.2 Global Opioid Induced Constipation Drugs Market Size by Application (2012-2017)
    4.3 Potential Application of Opioid Induced Constipation Drugs in Future
    4.4 Top Consumer/End Users of Opioid Induced Constipation Drugs

5 United States Opioid Induced Constipation Drugs Development Status and Outlook
    5.1 United States Opioid Induced Constipation Drugs Market Size (2012-2017)
    5.2 United States Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Opioid Induced Constipation Drugs Development Status and Outlook
    6.1 EU Opioid Induced Constipation Drugs Market Size (2012-2017)
    6.2 EU Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Opioid Induced Constipation Drugs Development Status and Outlook
    7.1 Japan Opioid Induced Constipation Drugs Market Size (2012-2017)
    7.2 Japan Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Opioid Induced Constipation Drugs Development Status and Outlook
    8.1 China Opioid Induced Constipation Drugs Market Size (2012-2017)
    8.2 China Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Opioid Induced Constipation Drugs Development Status and Outlook
    9.1 India Opioid Induced Constipation Drugs Market Size (2012-2017)
    9.2 India Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Opioid Induced Constipation Drugs Development Status and Outlook
    10.1 Southeast Asia Opioid Induced Constipation Drugs Market Size (2012-2017)
    10.2 Southeast Asia Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Opioid Induced Constipation Drugs Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
        11.1.2 EU Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
        11.1.4 China Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
        11.1.5 India Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
    11.2 Global Opioid Induced Constipation Drugs Market Size (Value) by Type (2017-2022)
    11.3 Global Opioid Induced Constipation Drugs Market Size by Application (2017-2022)

12 Opioid Induced Constipation Drugs Market Dynamics
    12.1 Opioid Induced Constipation Drugs Market Opportunities
    12.2 Opioid Induced Constipation Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Opioid Induced Constipation Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Opioid Induced Constipation Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source